(function(){var loadHandler=window['sl_{58BE4C92-4C81-45BB-BC6E-D3FA2D7DCBC6}'];loadHandler&&loadHandler(52, '<div id="spr0_68af0d9"><div id="spr1_68af0d9" class="kern slide"><img id="img0_68af0d9" src="data/img2.png" width="960px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_68af0d9" class="kern slide"><div id="spr3_68af0d9" style="left:90.415px;top:45.336px;"><div style="width:0px;"><span id="txt0_68af0d9" class="nokern" data-width="258.794678" style="left:260.257px;top:7.302px;">Rhythm Control</span></div></div><div id="spr4_68af0d9" style="left:90.415px;top:124.724px;"><div style="width:0px;"><span id="txt1_68af0d9" class="nokern relpos" dir="auto" style="left:24.265px;top:5.069px;">●</span> <span id="txt2_68af0d9" class="nokern relpos" data-width="316.039063" style="left:46.324px;top:8.783px;">Not every patient qualifies for the treatment</span></div><div style="width:0px;"><span id="txt3_68af0d9" class="nokern relpos" dir="auto" style="left:24.265px;top:43.469px;">●</span> <span id="txt4_68af0d9" class="nokern relpos" data-width="82.539063" style="left:46.324px;top:47.183px;">Indications:</span></div><div style="width:0px;"><span id="txt5_68af0d9" class="nokern relpos" dir="auto" style="left:72.265px;top:82.095px;">○</span> <span id="txt6_68af0d9" class="nokern relpos" data-width="150.304688" style="left:89.52px;top:85.809px;">Persistent symptoms</span></div><div style="width:0px;"><span id="txt7_68af0d9" class="nokern relpos" dir="auto" style="left:72.265px;top:103.215px;">○</span> <span id="txt8_68af0d9" class="nokern relpos" data-width="288.046875" style="left:89.52px;top:106.929px;">Inability to reach ventricular rate control</span></div><div style="width:0px;"><span id="txt9_68af0d9" class="nokern relpos" dir="auto" style="left:72.265px;top:124.335px;">○</span> <span id="txt10_68af0d9" class="nokern relpos" data-width="374.835938" style="left:89.52px;top:128.049px;">Need for maintenance of normal sinus rhythm (NSR)</span></div><div style="width:0px;"><span id="txt11_68af0d9" class="nokern relpos" dir="auto" style="left:72.265px;top:145.455px;">○</span> <span id="txt12_68af0d9" class="nokern relpos" data-width="225.796875" style="left:89.52px;top:149.169px;">High cardiovascular risk patient</span></div><div style="width:0px;"><span id="txt13_68af0d9" class="nokern relpos" dir="auto" style="left:72.265px;top:166.575px;">○</span> <span id="txt14_68af0d9" class="nokern relpos" data-width="183.437500" style="left:89.52px;top:170.289px;">Patients with heart failure</span></div><div style="width:0px;"><span id="txt15_68af0d9" class="nokern relpos" dir="auto" style="left:24.265px;top:206.669px;">●</span> <span id="txt16_68af0d9" class="nokern relpos" data-width="663.507813" style="left:46.324px;top:210.383px;">Conversion to NSR is established by cardioversion and then maintained with antiarrhythmics</span></div><div style="width:0px;"><span id="txt17_68af0d9" class="nokern relpos" dir="auto" style="left:72.265px;top:245.069px;">○</span> <span id="txt18_68af0d9" class="nokern relpos" data-width="563.093750" style="left:89.52px;top:248.783px;">Cardioversion increases thromboembolism so the patient should be started on</span></div><div style="width:0px;"><span id="txt19_68af0d9" class="nokern" data-width="462.484375" style="left:105.598px;top:267.983px;">anticoagulation 3 weeks before cardioversion and 4 weeks after.</span></div><div style="width:0px;"><span id="txt20_68af0d9" class="nokern relpos" dir="auto" style="left:24.265px;top:302.669px;">●</span> <span id="txt21_68af0d9" class="nokern relpos" data-width="485.851563" style="left:46.324px;top:306.383px;">Antiarrhythmic (AAD) choice based on patient’s past medical history</span></div></div><div id="spr5_68af0d9" style="left:312.448px;top:509.091px;"><div style="width:0px;"><span id="txt22_68af0d9" class="nokern relpos" data-width="74.122673" style="left:24.619px;top:2.945px;">CREATED BY </span> <span id="txt23_68af0d9" class="nokern relpos" data-width="86.416077" style="left:24.613px;top:1.654px;">ALBATENIUS</span> <span id="txt24_68af0d9" class="nokern relpos" data-width="142.016022" style="left:24.606px;top:2.945px;"> – ALL RIGHTS RESERVED.</span></div><div style="width:0px;"><span id="txt25_68af0d9" class="nokern relpos" data-width="151.178696" style="left:40.199px;top:13.798px;">FOR MORE CONTENT VISIT </span> <span id="txt26_68af0d9" class="nokern relpos" data-width="119.884079" style="left:40.193px;top:12.508px;">ALBATENIUS.COM</span></div></div><a id="hl0_68af0d9" href="http://www.albatenius.com/" title="http://www.albatenius.com/" target="_blank" onclick="document.getElementById(\'coreSpr_9063454\').getCore().processTriggerEffect(this);return document.getElementById(\'coreSpr_9063454\').getCore().gotoLink(this);" style="left:339.528px;top:509.091px;"><div id="svg0_68af0d9" style="left:0px;top:0px;"><svg width="295" height="31" viewBox="0 0 295 31"><path fill="#000000" fill-opacity="0" d="M0,0 h294.546 v30.909 h-294.546 Z"/></svg></div></a></div></div>', '{"s":[]}');})();